Detailing the effects of polypharmacy in psychiatry: longitudinal study of 320 patients hospitalized for depression or schizophrenia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1433-8491
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Detailing the effects of polypharmacy in psychiatry: longitudinal study of 320 patients hospitalized for depression or schizophrenia ; day:25 ; month:11 ; year:2021 ; pages:1-17
European archives of psychiatry and clinical neuroscience ; (25.11.2021), 1-17
- Urheber
-
Stassen, H. H.
Bachmann, S.
Bridler, R.
Cattapan, K.
Herzig, D.
Schneeberger, A.
Seifritz, E.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00406-021-01358-5
- URN
-
urn:nbn:de:101:1-2022020119153318046822
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Stassen, H. H.
- Bachmann, S.
- Bridler, R.
- Cattapan, K.
- Herzig, D.
- Schneeberger, A.
- Seifritz, E.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
Polypharmacy in psychiatry and weight gain: longitudinal study of 832 patients hospitalized for depression or schizophrenia, along with data of 3180 students from Europe, the U.S., South America, and China
Cost of antipsychotic polypharmacy in the treatment of schizophrenia
Polypharmacy in schizophrenia - therapeutic option or a sign of despair?
Antipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations
Multimorbidity and polypharmacy in hospitalized older patients: a cross-sectional study
Polypharmacy in a hospitalized psychiatric population: risk estimation and damage quantification
Antipsychotic patterns of use in patients with schizophrenia: polypharmacy versus monotherapy
Drug utilization patterns among elderly hospitalized patients on poly-pharmacy in Punjab, Pakistan
Antipsychotic polypharmacy and metabolic syndrome in schizophrenia: a review of systematic reviews
Polypharmacy and the risk of drug–drug interactions and potentially inappropriate medications in hospital psychiatry
Tramp (detailing his day's work)
Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
Polypharmacy in psychiatry and weight gain: longitudinal study of 832 patients hospitalized for depression or schizophrenia, along with data of 3180 students from Europe, the U.S., South America, and China
Cost of antipsychotic polypharmacy in the treatment of schizophrenia
Polypharmacy in schizophrenia - therapeutic option or a sign of despair?
Antipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations
Multimorbidity and polypharmacy in hospitalized older patients: a cross-sectional study
Polypharmacy in a hospitalized psychiatric population: risk estimation and damage quantification
Antipsychotic patterns of use in patients with schizophrenia: polypharmacy versus monotherapy
Drug utilization patterns among elderly hospitalized patients on poly-pharmacy in Punjab, Pakistan
Antipsychotic polypharmacy and metabolic syndrome in schizophrenia: a review of systematic reviews
Polypharmacy and the risk of drug–drug interactions and potentially inappropriate medications in hospital psychiatry
Tramp (detailing his day's work)
Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
Polypharmacy in psychiatry and weight gain: longitudinal study of 832 patients hospitalized for depression or schizophrenia, along with data of 3180 students from Europe, the U.S., South America, and China
Cost of antipsychotic polypharmacy in the treatment of schizophrenia
Polypharmacy in schizophrenia - therapeutic option or a sign of despair?
Antipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations
Multimorbidity and polypharmacy in hospitalized older patients: a cross-sectional study
Polypharmacy in a hospitalized psychiatric population: risk estimation and damage quantification
Antipsychotic patterns of use in patients with schizophrenia: polypharmacy versus monotherapy
Drug utilization patterns among elderly hospitalized patients on poly-pharmacy in Punjab, Pakistan
Antipsychotic polypharmacy and metabolic syndrome in schizophrenia: a review of systematic reviews
Polypharmacy and the risk of drug–drug interactions and potentially inappropriate medications in hospital psychiatry